Login to Your Account

ASCO 2013

Nanobiotix Nanoparticle Targets Radiotherapy Effects on Tumors

By Nuala Moran
Staff Writer

Wednesday, June 5, 2013
LONDON – Nanobiotix SA presented positive safety data from the first clinical study of NBTXR3, a nanoparticle drug that enhances the effects of radiotherapy on tumor cells without damaging healthy tissue, at the American Society of Clinical Oncology (ASCO) meeting in Chicago on Saturday.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription